by Nathan Cole | Sep 23, 2026 | ALS, ALS Research, Newsletter
by Nathan Cole | Aug 24, 2026 | ALS, ALS Research, Newsletter
It’s been several months since my last update, and I apologize for the gap. Life has kept me busy, including getting used to a new eye-tracking device. It’s essentially an iPad with a cursor synced to my eye movement, letting me operate it entirely...
by Nathan Cole | May 8, 2026 | ALS, ALS Research, Newsletter
🏈 Join the fight against ALS with an afternoon of football and purpose! On Sunday, June 14, the Arizona Rattlers and Precision ALS, powered by the Cortexa Therapeutics Fund, are teaming up to raise awareness and support critical #ALS research during the Rattlers’...
by Nathan Cole | Feb 12, 2026 | ALS, ALS Research, Newsletter
Research Update – Phase 1b & Phase 2 Underway Advancing Target Validation and Strengthening the Mechanistic Foundation. We are pleased to share that Phase 1b and Phase 2 of our six phase validation roadmap are currently underway with our CRO partner in Scotland....
by Nathan Cole | Jan 15, 2026 | ALS, ALS Research, Newsletter
In case you missed Ahwatukee Foothills News feature on Cortexa’s founder, “Ahwatukee man fights for his life” please find it linked here. Cortexa Needs You I’m working to raise $15,000 to fund the next phase of our research at Cortexa Therapeutics, where we are...